Results

Total Results: 1,269 records

Showing results for "author year description".

461. Prehospital EMS Blood Transfusion and Fluid Interventions for Hemorrhagic Shock (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ems-blood-transfusion-protocol-amendment.pdf
     February 04, 2025 - military trauma is hemorrhagic shock.1 Hemorrhage in trauma patients accounts for over 60,000 deaths per year … in the United States and 1.5 million per year globally, and is second only to central nervous system … and Fluid Interventions for Hemorrhagic Shock 10 Protocol – Pacific Northwest EPC Contacting Author … For each included study, we will extract general study characteristics (e.g., authors, year of publication … Finally, a final version of the narrative summary and description of the diagram(s) will be prepared

462. Disposition of Comments: Management of Colonic Diverticulitis (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/diverticulitis-comments.pdf
     October 12, 2020 - field_product_pub_date https://effectivehealthcare.ahrq.gov/exit-disclaimer/ Summary of Peer Reviewer Comments and Author … effectivehealthcare.ahrq.gov/products/diverticulitis/research Published Online: October 12, 2020 4 Public Comments and Author … affect risk of recurrence or quality of life but may reduce the need for surgery over the following year … Management of Colonic Diverticulitis Comments to Draft Report Summary of Peer Reviewer Comments and Author … Response Public Comments and Author Response

463. Troponin Cardiac Marker Interpretation During Renal Function Impairment | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/renal-function/research-protocol
     December 01, 2019 - Short-term outcomes (all-cause mortality and MACE during the initial hospitalization or within 1 year … The outcomes of interest are: Long-term outcomes (all-cause mortality and MACE over at least 1 year … Long-term outcomes All-cause mortality MACE rates at ≥ 1 year   … These studies adhered to the commonly held concepts of high quality, including the following: a clear description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

464. Disposition of Comments for CERs 155 156 Contast-Induced Nephropathy (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
     January 07, 2016 - We use the definitions of CIN presented by each study author. … and year so it is hard to link the text to what is shown in the table. … We revised the text to refer to the author and year of each study to make it easier to link the text … “Control” has been changed to “Placebo” as this is the more appropriate description. 53 Technical … Table 1 description of the Populations explicitly states that the all routes of vascular contrast exposure

465. Appendicitis Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/appendicitis_research-protocol.pdf
     December 09, 2013 - emergency departments, with the number of cases in the USA estimated at approximately 3.4 million per year … Please see the preceding section for a detailed description of the populations, interventions, and outcomes … We will not restrict searches by year of publication. … Author contact will be by email (to the corresponding author of each study), with a primary contact … In the event of protocol amendments, the date of each amendment will be accompanied by a description

466. Fecal-Incontinence Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/fecal-incontinence_research-protocol.pdf
     November 30, 2014 - For reviews that were published previously on the same topic by the same author(s), only the most recent … From systematic reviews, we will extract author, year of publication, literature search dates, eligibility … These fields will include author, year of publication, setting, subject inclusion and exclusion criteria … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

467. Comparative Effectiveness of First and Second Generation Antipsychotics in the Pediatric and Young Adult Populations | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/antipsychotics-children/research-protocol
     December 01, 2019 - The following data will be extracted from each study: author identification, year of publication, source … Adverse events will be recorded for each intervention group including the description of the adverse … Psychotropic practice patterns for youth: a 10-year perspective. … Second generation antipsychotics: FDA status Drug FDA status (year approved) Indications

468. Pharmacologic and Nonpharmacologic Treatments of Posttraumatic Stress Disorder (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ptsd-repository-expanded-protocol.pdf
     October 24, 2019 - Data Management After studies are screened and determined to meet inclusion criteria, study design, year … each domain (selection, performance, detection, attrition, and reporting bias; see Appendix C for a description … Characteristics of included studies, such as number of publications by year, study sample size, proportion … Author b. Year of publication c. Bibliographic citation d. PubMed ID e.

469. Disposition of Comments for Comparative Effectiveness Review 130 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/preoperative-testing_disposition-comments.pdf
     January 29, 2014 - We rephrased some of the description of direct effects and added a parenthetical statement describing … Peer Reviewer #8 Methods Comparator of interest: it seems that the description mixed true comparators … For example, the choice of publication year as a criteria to evaluate applicability should be included … Please provide a description of methods in the method section with appropriate justification. … Peer Reviewer #8 Figures Page 19, lines 24-29 The description of the text is not consistent with

470. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
     April 01, 2011 - Peer Reviewer #6 Executive Summary Better description of applicability of evidence in the executive … They are approved for the symptom of frequent heartburn only up to 2 week courses x 3 in a year.” … In the appendix, it was noted that the study was rejected because it lacked a >5 year follow-up. … , have >5 year follow-up in 2010. 3- Other healing studies of 8 week duration without a >5 year follow-up … in patients who received high-dose, defined as multiple daily doses, and long-term PPI therapy (a year

471. Disposition of Comments Report for Methods for Insulin Delivery and Glucose Monitoring (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_disposition-comments.pdf
     January 01, 2010 - Given almost one year elapsed since then AHRQ may want to consider an updated search. … We excluded all studies published prior to 1994, the year when insulin analogues were introduced. … We excluded all studies published prior to 1994, the year when insulin analogues were introduced. … We believe this title is an accurate description of what our report examines. … Methods chapter and the Methods Guide for Effectiveness and Comparative Effectiveness Reviews for a description

472. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb-disposition.pdf
     March 10, 2010 - In the revised version of our CER, we have included a detailed description of the methods utilized in … Four of the seven studies included here have less than 1 year follow (compared to 4-5 yearly in the

473. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
     January 01, 2015 - We have added a sentence on this in the Executive Summary study characteristics description for the … exact range of study duration if the studies are longer than 1 year. … Results Page 112 The word cerebrovascular is used when the author probably intended to say cardiovascular … Please reconcile.pp. 126 130 139 209 Tables 36 40 41 45 70Please consider adding Author Year and Followup … Most studies had adults with diabetes in the 5-7 year range.

474. Progestogens for the Prevention of Preterm Birth | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/progestogens-preterm-birth/research-protocol
     December 01, 2019 - annually, and is projected to reduce initial neonatal medical costs by more than $505 million each year … table will vary according to Key Question, but the Tables will contain some common elements (e.g., author … , publication year, study location, time period, population description, sample size, and study type) … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

475. Rapid Response: Efficacy of Dental Services for Reducing Adverse Events in Those Receiving Chemotherapy for Cancer (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rapid-response-chemotherapy-dental.pdf
     July 01, 2023 - Table of included studies Author, Year Country Funding Source Outcome Design Rate of Outcome … No differences were statistically significant. 22 Author, Year Country Funding Source … Relevant guideline recommendations Author, Year Organization(s) Title Year Population Recommendation … All recommendations recorded in this C-4 Author, Year Organization(s) Title Year Population … Information to be shared includes C-5 Author, Year Organization(s) Title Year Population

476. EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-sepsis.pdf
     July 01, 2023 - Control and Prevention (CDC) estimate that at least 1.7 million adults in America develop sepsis every year … Information will be organized according to the review questions, and will include author, year, study … rationale for the PSP, outcomes, implementation barriers and facilitators, required resources, and description

477. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/adhd_research-protocol.pdf
     August 10, 2010 - Abstracted data will include study characteristics (e.g., first author, country of research origin, … A 23-year comparison. J Abnorm Child Psychol 2003 Feb;31(1):1- 11. 9.

478. AHRQ Slide Template 2009 (ppt file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/reporting.ppt
     September 01, 2009 - One review author extracted the…data…and the second author checked the extracted data. … The level of detail that should be included in the description of the data collection process is illustrated … PMID: 20704036 References (VII) Author This presentation was prepared by David Moher, Ph.D., director … Author

479. Disposition of Comments for CER 167 Renal Masses (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/renal-cancer_disposition-comments.pdf
     February 24, 2016 - For example a new baseline GFR of 50 for a 75 year old male may not be an issue, 57 year old male ( … median age of diagnosis for RCC) who has a 20 year life expectancy otherwise may certainly be. … studies reporting these subgroups and outcomes, and the few studies reporting follow-up beyond one year … analysis is limited by power and by limited data on long-term renal functional outcomes (beyond 1 year … RCC incidence is a well- documented phenomenon, demonstrating an increase in incidence of 2-3% per year

480. Assessing Applicability (ppt file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/assessing-applicability.ppt
     January 01, 2009 - ACE inhibitor use, 34%; ß-blocker use, 40%) Hospitali-zations and survival Median followup at 1 year … Applicability Summary Table Template Domain Description of Applicability Evidence for a Key Question … Completed Applicability Summary Table Domain Description of Applicability Evidence for a Key Question … DOI: 10.1503/cmaj.090523 References Author This presentation was prepared by C. … Author